person
as of 2026-07-01Richard Keefe, PhD
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 12
2 publications · 2 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Schizophrenia Trials Network
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
12
Publications
2 (2 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
2
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
NCT01422902Phase 2Completed
Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network
NCT00930150Phase 4Completed
Publications & congress
2
Structural and construct validity assessment of the schizophrenia cognition rating scale (SCoRS) using data from three international phase 3 randomized controlled trials (CONNEX programme).
Schizophrenia research · 2026 · high-value
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials.
The American journal of psychiatry · 2025 · high-value
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here